Annals of Oncology

News:

Cancer mortality up, life expentancy down in Eastern Europe
Ann Oncol 11: 1073.
[PDF] [Request Permissions]

Tobacco companies tried to destroy WHO
Ann Oncol 11: 1073-1074.
[PDF] [Request Permissions]

Roche closes down prestigious institute
Ann Oncol 11: 1074.
[PDF] [Request Permissions]

More money for the NHS: Will it work better?
Ann Oncol 11: 1074.
[PDF] [Request Permissions]

US administration halts cancer tests in Oklahoma
Ann Oncol 11: 1074-1075.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 11: 1075-1077.
[PDF] [Request Permissions]

Book reviews:

S. Bodis

Book review
Ann Oncol 11: 1078.
[PDF] [Request Permissions]

M. Alerci

Book review
Ann Oncol 11: 1210.
[PDF] [Request Permissions]

Editorials:

A. Costa

Breast cancer and the axilla: Not entirely out of the labyrinth
Ann Oncol 11: 1079-1080.
[PDF] [Request Permissions]

R. Newton

Infections and human cancer
Ann Oncol 11: 1081-1082.
[PDF] [Request Permissions]

Reviews:

D. Giuffrida and H. Gharib

Anaplastic thyroid carcinoma: Current diagnosis and treatment
Ann Oncol 11: 1083-1089.
[Abstract] [PDF] [Request Permissions]

S. Franceschi

Strategies to reduce the risk of virus-related cancers
Ann Oncol 11: 1091-1096.
[Abstract] [PDF] [Request Permissions]

Original articles:

R. Gonzalez, J. M. Silva, A. Sanchez, G. Dominguez, J. M. Garcia, X. qi Chen, M. Stroun, M. Provencio, P. España, P. Anker, and F. Bonilla

Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance
Ann Oncol 11: 1097-1104.
[Abstract] [PDF] [Request Permissions]

C. Engel, M. Loeffler, S. Schmitz, H. Tesch, V. Diehl, and German Hodgkin's Lymphoma Study Group (GHSG)

Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease
Ann Oncol 11: 1105-1114.
[Abstract] [PDF] [Request Permissions]

C. Kollmannsberger, C. Nichols, C. Meisner, F. Mayer, L. Kanz, and C. Bokemeyer

Identification of prognostic subgroups among patients with metastatic ‘IGCCCG poor-prognosis’ germ-cell cancer: An explorative analysis using cart modeling
Ann Oncol 11: 1115-1120.
[Abstract] [PDF] [Request Permissions]

B. L. van Leeuwen, W. A. Kamps, R. M. Hartel, R. P. H. Veth, W. J. Sluiter, and H. J. Hoekstra

Effect of single chemotherapeutic agents on the growing skeleton of the rat
Ann Oncol 11: 1121-1126.
[Abstract] [PDF] [Request Permissions]

S. Ricci, A. Antonuzzo, L. Galli, M. Ferdeghini, L. Bodei, C. Orlandini, and P. F. Conte

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide
Ann Oncol 11: 1127-1130.
[Abstract] [PDF] [Request Permissions]

M. Escher and A.-P. Sappino

Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition
Ann Oncol 11: 1131-1135.
[Abstract] [PDF] [Request Permissions]

M. Greco, M. Gennaro, P. Valagussa, R. Agresti, C. Ferraris, B. Ferrari, C. Urban, L. Gianni, and for the Istituto Nazionale per lo Studio e la Cura dei Tumori

Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer
Ann Oncol 11: 1137-1140.
[Abstract] [PDF] [Request Permissions]

S. M. Lichtman, D. Niedzwiecki, M. Barcos, T. L. Carlisle, M. R. Cooper, J. L. Johnson, B. A. Peterson, and for the Cancer and Leukemia Group B

Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255
Ann Oncol 11: 1141-1146.
[Abstract] [PDF] [Request Permissions]

R. H. De Boer, W. H. Allum, S. R. Ebbs, G. P. H. Gui, S. R. D. Johnston, N. P. M. Sacks, G. Walsh, S. Ashley, and I. E. Smith

Multimodality therapy in inflammatory breast cancer: Is there a place for surgery?
Ann Oncol 11: 1147-1153.
[Abstract] [PDF] [Request Permissions]

M. Vassilomanolakis, G. Koumakis, V. Barbounis, M. Demiri, H. Pateras, and A. P. Efremidis

Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
Ann Oncol 11: 1155-1160.
[Abstract] [PDF] [Request Permissions]

A. B. Sandler, H. L. Kindler, L. H. Einhorn, E. Mitchell, G. Masters, M. Kraut, S. Nicol, and D. Raghavan

Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction
Ann Oncol 11: 1161-1164.
[Abstract] [PDF] [Request Permissions]

D. R. Ferry, M. Deakin, J. Baddeley, S. Daryanani, S. Bramhall, D. A. Anderson, M. J. O. Wakelam, J. Doran, G. Pemberton, A. M. Young, J. Buckels, and D. J. Kerr

A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: Correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints
Ann Oncol 11: 1165-1170.
[Abstract] [PDF] [Request Permissions]

A. Tavani, S. Gallus, C. La Vecchia, E. Conti, M. Montella, and S. Franceschi

Aspirin and ovarian cancer: An Italian case-control study
Ann Oncol 11: 1171-1173.
[Abstract] [PDF] [Request Permissions]

J. Herod, A. Burton, J. Buxton, J. Tobias, D. Luesley, S. Jordan, J. Dunn, and C. J. Poole

A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix
Ann Oncol 11: 1175-1181.
[Abstract] [PDF] [Request Permissions]

M. M. Vaughan, J. Moore, P. G. Riches, S. R. D. Johnston, R. P. A'Hern, M. E. Hill, T. Eisen, M. J. Ayliffe, J. M. Thomas, and M. E. Gore

GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma
Ann Oncol 11: 1183-1189.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

R. Barceló, G. López-Vivanco, J. M. Mañé, I. Rubio, A. Muñoz, and R. Fernández

Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: Description of four cases
Ann Oncol 11: 1191-1194.
[PDF] [Request Permissions]

D. F. Moffat, K. A. Oien, J. Dickson, T. Habeshaw, and D. R. McLellan

Hepatocellular carcinoma after long-term tamoxifen therapy
Ann Oncol 11: 1195-1196.
[Abstract] [PDF] [Request Permissions]

D. A. Anthoney, I. Bone, and T. R. J. Evans

Inflammatory demyelinating polyneuropathy: A complication of immunotherapy in malignant melanoma
Ann Oncol 11: 1197-1200.
[Abstract] [PDF] [Request Permissions]

Short reports:

G. Ciccone, C. Prastaro, C. Ivaldi, R. Giacometti, and P. Vineis

Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status
Ann Oncol 11: 1201-1204.
[PDF] [Request Permissions]

A. J. Gelderblom, W. J. Loos, M. J. A. de Jonge, A. Sparreboom, A. S. T. Planting, M. E. L. van der Burg, E. Brouwer, C. Verheij, L. Ouwens, S. Hearn, and J. Verweij

Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin
Ann Oncol 11: 1205-1207.
[PDF] [Request Permissions]

Letter to the editor:

M. K. Altundag, I. Çelik, and Y. Özisik

Is there a range of time for initiation of adjuvant chemotherapy in patients with malignancy?
Ann Oncol 11: 1209.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.